protective immunity Archives

Questions For Those Offering You A ‘Vaccine’.

4 May 2021

Beware ‘Excited’ Non-Healthcare Workers. As another cohort is now to be offered the antivirals (they are not vaccines), it is apposite to set out some questions to ask those who are falling over themselves to vaccinate you. There is an irony in the fact that reception staff at GPs’ surgeries who are usually obdurate and […]

IgA – Faster, Stronger and More Effective.

11 March 2021

The Star Player On Your Team. Following seroconversion, immumoglobulin A (IgA) istoype is the most frequently created antibody in the immune system. This is principally because it dominates the upper respiratory tract, which is usually the first point of contact between pathogen and human. Therefore, it is needed more frequently than the other isotypes. As […]

Calcifediol (Vitamin D) Is The Most Effective Vaccine.

14 February 2021

Our Position On Calcifediol Is Validated Again. In early July 2020 we identified the importance of vitamin D in respect of SARS-CoV-2, both in terms of systematic vitamin D deficiency leading to increased COVID-19 disease severity & resultant higher mortality rates and the role of vitamin D in providing protective or sterilising immunity. Natural exposure […]

Why The S Protein Is Not The Target You Are Looking For.

11 February 2021

The First Lesson Of Camouflage – Not Being Seen. The majority of vaccines and antivirals both in use and in development as SARS-CoV-2 countermeasures target the structural Spike protein. We have highlighted previously that as the S protein trimers contain the RBDs, the S protein houses the virion’s principal weapon and is therefore the obvious, […]

Nitric Oxide Immunity In The Upper Respiratory Tract.

24 January 2021

The Upper Respiratory Tract Is The Key Battleground. Back in July 2020, we first explained the crucial significance of vitamin D as an effective viral countermeasure as well as the significance of vitamin D deficiency in SARS-CoV-2’s pathogenesis and COVID-19 disease severity. Then in October we highlighted the importance of the vitamin D→endothelial nitric oxide synthase→nitric […]

Antibody-Dependent Enhancement And This Rushed ‘Vaccine’.

19 January 2021

What is Antibody-Dependent Enhancement? As we have set out previously, it takes 10-15 years to develop a vaccine. This timescale is entirely understandable and justifiable when you consider that the vaccine has to be both effective and safe. Safe includes not causing unacceptable side effects, which include the vaccine or immune system’s response triggering autoimmunity, […]

N501Y Is More Infectious But NOT More Dangerous.

13 January 2021

Infectiousness Or Infectivity. If the government is to be believed, the new killer mutant of death (no, not vaccines minister Zoonotic Gaddafi, the other killer mutant of death known as N501Y) is even more infectious and even more transmissible. Except the government likes to confuse viral infectiousness with disease severity. They are very different. Also, […]

Why Government Advice Makes It So Much Worse.

5 January 2021

Over nine months into this insanity, it is clear that government advice hasn’t worked. Following government advice doesn’t work. Not only is government advice ineffective but also it causes negative outcomes. Following government advice makes the situation worse and makes you far more likely to become seriously ill and – if you allow yourself to […]

Exoribonuclease – Your Starter For Ten Mr Prime Minister.

30 December 2020

Q1. How can a virus containing an exoribonuclease mutate in the way you are saying? Coronaviruses possess an exoribonuclease within nonstructural protein 14 (nsp14-ExoN). This functions as a proofreader during viral transcription and encoding, ensuring high fidelity replication. This minimises the potential for mutation, as shown by the fact that sarbecovirus/lineage B betacoronaviruses with their […]